Literature DB >> 22569469

Targeted corneal transplantation.

Vishal Jhanji1, Jod S Mehta, Namrata Sharma, Bhavana Sharma, Rasik B Vajpayee.   

Abstract

PURPOSE OF REVIEW: Corneal transplantation surgery has moved from an era of conventional penetrating keratoplasty to selective replacement of the diseased corneal layer with complementary healthy donor corneal tissue. Anterior lamellar transplantation surgeries do not involve replacement of corneal endothelium, consequently eliminating the occurrence of endothelial rejection. Similarly, in diseases affecting the corneal endothelium, selective replacement with a lamellar lenticule bearing healthy endothelium provides better outcomes in terms of ocular surface, lesser astigmatism and quick visual recovery. In addition to the advantages of enhanced surgical outcomes, targeted corneal transplantation allows the use of one donor cornea for more than one recipient, thereby offering a viable solution to the problem of paucity of donor corneas. RECENT
FINDINGS: Evolving techniques of corneal transplantation have enabled better utilization of donor corneal tissue. Anterior lamellar as well as endothelial keratoplasty surgeries have become first-choice surgeries in appropriately selected cases. This review briefly discusses some of these novel surgical techniques.
SUMMARY: A better understanding of targeted corneal transplantation would lead to adaptation of the concept of component corneal surgery. This would further enable the corneal surgeons to circumvent the problem of donor corneal shortage especially in the developing world.

Entities:  

Mesh:

Year:  2012        PMID: 22569469     DOI: 10.1097/ICU.0b013e32835484a1

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  8 in total

1.  Customised component corneal transplantation: a blessing for three patients.

Authors:  Alok Sati; Sandeep Shankar; Ashok Jha; Velamakanni Satyanarayana Gurunadh
Journal:  BMJ Case Rep       Date:  2014-08-21

Review 2.  Corneal tissue engineering: recent advances and future perspectives.

Authors:  Chiara E Ghezzi; Jelena Rnjak-Kovacina; David L Kaplan
Journal:  Tissue Eng Part B Rev       Date:  2015-02-10       Impact factor: 6.389

3.  The effects of Rho-associated kinase inhibitor Y-27632 on primary human corneal endothelial cells propagated using a dual media approach.

Authors:  Gary S L Peh; Khadijah Adnan; Benjamin L George; Heng-Pei Ang; Xin-Yi Seah; Donald T Tan; Jodhbir S Mehta
Journal:  Sci Rep       Date:  2015-03-16       Impact factor: 4.379

Review 4.  Component corneal surgery: An update.

Authors:  Prafulla K Maharana; Pranita Sahay; Deepali Singhal; Itika Garg; Jeewan S Titiyal; Namrata Sharma
Journal:  Indian J Ophthalmol       Date:  2017-08       Impact factor: 1.848

5.  Optimisation of Storage and Transportation Conditions of Cultured Corneal Endothelial Cells for Cell Replacement Therapy.

Authors:  Stephen Wahlig; Gary S L Peh; Khadijah Adnan; Heng-Pei Ang; Chan N Lwin; F Morales-Wong; Hon Shing Ong; Matthew Lovatt; Jodhbir S Mehta
Journal:  Sci Rep       Date:  2020-02-03       Impact factor: 4.379

Review 6.  Biomaterials for corneal endothelial cell culture and tissue engineering.

Authors:  Mohit Parekh; Vito Romano; Kareem Hassanin; Valeria Testa; Rintra Wongvisavavit; Stefano Ferrari; Atikah Haneef; Colin Willoughby; Diego Ponzin; Vishal Jhanji; Namrata Sharma; Julie Daniels; Stephen B Kaye; Sajjad Ahmad; Hannah J Levis
Journal:  J Tissue Eng       Date:  2021-02-16       Impact factor: 7.813

7.  Morphological Changes of Human Corneal Endothelial Cells after Rho-Associated Kinase Inhibitor Eye Drop (Ripasudil) Administration: A Prospective Open-Label Clinical Study.

Authors:  Hiroko Nakagawa; Noriko Koizumi; Naoki Okumura; Hideki Suganami; Shigeru Kinoshita
Journal:  PLoS One       Date:  2015-09-14       Impact factor: 3.240

8.  Manual Medium Incision Cataract Surgery with Descemet's Stripping Endothelial Keratoplasty: A Novel Triple Procedure.

Authors:  Alvin L Young; Prudence P C Chow; Vishal Jhanji
Journal:  Int Sch Res Notices       Date:  2015-01-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.